ConductScience.org, home
Safety and Efficacy Study of Sotagliflozin on Glucose Control in Participants With Type 2 Diabetes, Moderate Impairment of Kidney Function, and Inadequate Blood Sugar Control
API referenceFor AI assistants

Trial · NCT03242252

Adverse events375

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

101 to 120 of 375

Download this page as JSON
TypeEventOrgan systemGroupAffectedAt riskEvents
seriousLimb injuryInjury, poisoning and procedural complicationsSotagliflozin 200 mg1267
seriousLimb injuryInjury, poisoning and procedural complicationsSotagliflozin 400 mg0260
seriousProcedural shockInjury, poisoning and procedural complicationsPlacebo0260
seriousProcedural shockInjury, poisoning and procedural complicationsSotagliflozin 200 mg1267
seriousProcedural shockInjury, poisoning and procedural complicationsSotagliflozin 400 mg0260
seriousRib fractureInjury, poisoning and procedural complicationsPlacebo1260
seriousRib fractureInjury, poisoning and procedural complicationsSotagliflozin 200 mg0267
seriousRib fractureInjury, poisoning and procedural complicationsSotagliflozin 400 mg0260
seriousTibia fractureInjury, poisoning and procedural complicationsPlacebo1260
seriousTibia fractureInjury, poisoning and procedural complicationsSotagliflozin 200 mg0267
seriousTibia fractureInjury, poisoning and procedural complicationsSotagliflozin 400 mg0260
seriousBlood creatinine increasedInvestigationsPlacebo0260
seriousBlood creatinine increasedInvestigationsSotagliflozin 200 mg1267
seriousBlood creatinine increasedInvestigationsSotagliflozin 400 mg0260
seriousBlood pressure increasedInvestigationsPlacebo1260
seriousBlood pressure increasedInvestigationsSotagliflozin 200 mg0267
seriousBlood pressure increasedInvestigationsSotagliflozin 400 mg0260
seriousAcute myocardial infarctionCardiac disordersPlacebo2260
seriousAcute myocardial infarctionCardiac disordersSotagliflozin 200 mg2267
seriousAcute myocardial infarctionCardiac disordersSotagliflozin 400 mg2260

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Previous pageNext page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03242252/events?page=6

API referenceFor AI assistants